Strain Phage Detection Service for Microbial Cell Bank Release

Overview Regulatory Basis Detection Methods Technical Advantages FAQ

Overview

Phage contamination is one of the most destructive risks in microbial expression systems. Unlike bacterial or fungal contaminants, phages are unaffected by antibiotics. An outbreak in a fermenter can lyse the entire host cell population within hours, leading to batch failure, production interruption, and even facility contamination. ICH Q5D classifies phages as adventitious agents and requires risk assessment based on process specificity, but provides no specific methodological guidance – phage detection is not described in any pharmacopoeia as a standard method.

Creative Biogene offers a complete service package covering lytic phage detection, lysogenic phage detection, and phage NGS identification. Our technical team can develop and validate custom detection protocols for various host strains, including E. coli, yeast, Bacillus, and lactic acid bacteria, supporting compliance needs from R&D through GMP manufacturing.

Double Layer Agar Plaque Assay

Phages lyse host bacteria in the bacterial lawn, forming clear, sterile zones called plaques. Since one infectious phage particle typically produces one plaque, the phage titer in a sample can be calculated as PFU/mL. This method was systematically standardized and validated in 2024. Plaque size shows a strong negative correlation with the minimum PFU required for lawn clearance, with an R² of 98.91%. It applies to various host genera, including Escherichia, Salmonella, Staphylococcus, and Pseudomonas.

Procedure: Prepare and solidify a base agar layer. Mix the host bacterial suspension with the test sample and add it to the molten soft agar overlay. Pour the overlay mixture onto the base agar. Incubate at an appropriate temperature and observe or quantify plaques.

Lytic Phage Detection

Directly detects the presence of lytic phage contamination in the cell bank. The test sample is mixed with log-phase sensitive host bacteria and plated. If lytic phages are present, transparent plaques form in the overlay.

Lysogenic (Prophage) Detection

Temperate phages integrate into the host genome as prophages and do not spontaneously lyse host cells. Mitomycin C is used to induce the host SOS response, forcing prophages to enter the lytic cycle and release active phage particles, which are then detected by the double-layer agar plaque assay. The addition of mitomycin C is a key improvement to address the issue of certain phages failing to form plaques under standard conditions.

Phage NGS Identification

Isolated phages undergo whole-genome sequencing. After de novo assembly, sequences are compared against the NCBI database to confirm species identity and genetic characteristics. This is suitable for confirming phage identity, assessing whether the phage carries toxin genes or other virulence factors, and tracing the source of contamination.

Regulatory Basis

Guideline / Document	Relevance
ICH Q5D Sections 4.3 and 2.3	Covers microbial cell banks; adventitious agent testing is a core requirement for cell bank characterization.
USP / EP	No monograph on phage detection.
GLP / GMP (ICH guidelines)	Methods can be validated per ICH guidelines to support GLP/GMP alignment.

Method Matrix

Method	Target	Turnaround	Compliance Level	Best For	Advantages	Limitations
Double layer agar plaque assay (lytic)	Lytic phages	Standard	GLP/GMP-aligned	MCB/WCB release, fermentation monitoring	Industry gold standard, quantitative	Some phages do not form plaques under standard conditions
Mitomycin C induction (lysogenic)	Prophages / temperate phages	Standard + 2 days	GLP/GMP-aligned	MCB/WCB release, strain bank evaluation	Detects phages integrated into the genome	Requires confirmation of induction conditions for the target host
Phage NGS identification	Phage species and genetic features	Standard + 5-7 days	GLP/GMP-aligned	Contamination source tracking, virulence factor assessment	Provides full genome information, traceable	Higher cost; requires isolated phage

For routine MCB/WCB release, we recommend performing both lytic and lysogenic detection. If a release test is positive, or if unexplained yield loss or lysis occurs during fermentation, we recommend adding NGS identification to confirm the phage species and assess potential risks.

Technical Advantages

Dual detection system covering lytic and lysogenic phages – ICH Q5D requires adventitious agent risk assessment to cover as broad a spectrum as possible. Our standard protocol includes both lytic phage detection and lysogenic prophage induction, ensuring that phages integrated into the host genome are not missed.
Transparent method validation – We provide complete validation reports including specificity, limit of detection, repeatability, and other key parameters, supporting both GLP and GMP alignment. Validation protocols and report formats are designed according to ICH guidelines and are directly usable for regulatory submissions.
Custom capability for non-E. coli hosts – Industry practice often limits phage detection to E. coli. Creative Biogene's team can develop and validate detection protocols for other production hosts such as Bacillus, lactic acid bacteria, and yeast, including method suitability confirmation, positive control selection, and validation parameter establishment.
Regulatory-ready compliance deliverables – Deliverables include complete method descriptions, raw data, result analysis, conclusions, and optional validation reports and certificates of analysis (CoA), all formatted to meet IND/BLA submission requirements.

Contact Us

Need a phage detection plan for your cell bank? Creative Biogene's technical team can provide a customized testing strategy based on your host strain type and project stage. Contact us for a technical proposal and pricing assessment.

FAQ

Q1: What are the limitations of the standard double-layer agar plaque assay? Does a negative result mean absolutely no phages?

A: The standard double-layer agar assay carries a risk of false negatives. Studies have shown that some phages, such as the Stx2 phage Sp5 of EHEC O157:H7, do not form visible plaques under standard conditions and require an improved method with mitomycin C and divalent cations for detection. Creative Biogene's strategy is to run standard conditions and mitomycin C induction in parallel for routine release testing. If phage contamination is still suspected during production despite a negative standard test, we can add an improved method or use an alternative method, such as a spot assay.

Q2: Can the test results be used directly for an IND submission?

A: Yes. Creative Biogene's test protocols and report formats are designed according to ICH Q5D and other ICH guidelines. Our phage detection reports can be placed in the "adventitious agent testing" or "cell bank characterization" section of IND/BLA submission dossiers. If you require GLP or GMP alignment, please specify the required compliance level at project initiation, and we will configure the appropriate quality system and provide validation documents and certificates of analysis.

* For research use only. Not intended for any clinical use.

Quick Inquiry